首页> 美国卫生研究院文献>Journal of Innate Immunity >A Nonsynonymous Polymorphism of IRAK4 Associated with Increased Prevalence of Gram-Positive Infection and Decreased Response to Toll-Like Receptor Ligands
【2h】

A Nonsynonymous Polymorphism of IRAK4 Associated with Increased Prevalence of Gram-Positive Infection and Decreased Response to Toll-Like Receptor Ligands

机译:IRAK4的非同义多态性与革兰氏阳性感染的患病率增加和对收费受体配体的响应降低有关。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutations in IRAK4 have been associated with recurrent Gram-positive infections in children. Given the central role of IRAK4 in innate immunity signaling, we hypothesized that common genetic variants of IRAK4 may be associated with prevalence of Gram-positive infection in critically ill adults. Haplotype clade tag single nucleotide polymorphisms (SNPs) of the IRAK4 gene were selected and genotyped in a cohort of 1,029 critically ill patients with systemic inflammatory response syndrome (SIRS). We found that a haplotype clade tagged by the A allele of the htSNP G29429A (Ala428Thr) was associated with increased relative risk of Gram-positive infection at admission to ICU (RR = 1.2, p < 0.05). Furthermore, the 29429A allele was associated with decreased lymphoblastoid cell response to CpG (as measured by IL-6 production) (raw values ± 95% CI 40.3 ± 32.3 vs. 85.8 ± 29.4 pg/ml; log-transformed values ± 95% CI 1.13 ± 0.37 vs. 1.55 ± 0.18, p < 0.04). We also found that IRAK4-deficient fibroblasts transfected with an IRAK4 expression plasmid containing the 29429A allele produced less IL-6 in response to lipopolysaccharide (p = 0.07). Our data suggest that the IRAK4 haplotype clade marked by 29429A (428Thr) alters susceptibility to Gram-positive bacteria, by decreasing cellular response to TLR ligands.Copyright © 2011 S. Karger AG, Basel
机译:IRAK4突变与儿童复发性革兰氏阳性感染有关。考虑到IRAK4在先天免疫信号传导中的核心作用,我们假设IRAK4的常见遗传变异可能与危重成年人革兰氏阳性感染的患病率有关。在一组1,029名系统性炎症反应综合征(SIRS)重症患者中,选择了IRAK4基因的单体型进化枝标签单核苷酸多态性(SNP)并进行了基因分型。我们发现由htSNP G29429A Ala等位基因(Ala428Thr)标记的单倍型进化枝与入ICU时革兰氏阳性感染的相对风险增加相关(RR = 1.2,p <0.05)。此外,29429A等位基因与CpG的淋巴母细胞反应降低有关(通过IL-6产生测量)(原始值±95%CI 40.3±32.3 vs.85.8±29.4 pg / ml;对数转化值±95%CI 1.13±0.37与1.55±0.18,p <0.04)。我们还发现,用含有29429A等位基因的IRAK4表达质粒转染的IRAK4缺陷成纤维细胞对脂多糖的反应产生的IL-6较少(p = 0.07)。我们的数据表明,标记为29429A(428Thr)的IRAK4单体型进化枝通过降低细胞对TLR配体的反应来改变对革兰氏阳性细菌的敏感性。版权所有©2011 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号